The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cancer Early Detection and Screening Market Research Report 2024
Synopsis
Cancer early detection and diagnosis are crucial in improving treatment outcomes and patient survival rates. Early detection involves identifying cancer at its earliest stages, even before symptoms become apparent.
Global Cancer Early Detection and Screening market is projected to reach US$ 373.7 million in 2029, increasing from US$ 246 million in 2022, with the CAGR of 6.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cancer Early Detection and Screening market research.
Key companies engaged in the Cancer Early Detection and Screening industry include Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic and Epigenomics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cancer Early Detection and Screening were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cancer Early Detection and Screening market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cancer Early Detection and Screening market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Exact Sciences
Grail
Genetron Health
New Horizon Health
Burning Rock
Berry Oncology
Shanghai Kunyuan Biotechnology
Oncognostic
Epigenomics
Abbott
Qiagen
iStat Biomedical
Segment by Type
Colorectal Cancer
Liver Cancer
Lung Cancer
Other
Segment by Application
Hospital
Medical Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cancer Early Detection and Screening report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Cancer early detection and diagnosis are crucial in improving treatment outcomes and patient survival rates. Early detection involves identifying cancer at its earliest stages, even before symptoms become apparent.
Global Cancer Early Detection and Screening market is projected to reach US$ 373.7 million in 2029, increasing from US$ 246 million in 2022, with the CAGR of 6.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cancer Early Detection and Screening market research.
Key companies engaged in the Cancer Early Detection and Screening industry include Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic and Epigenomics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cancer Early Detection and Screening were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cancer Early Detection and Screening market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cancer Early Detection and Screening market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Exact Sciences
Grail
Genetron Health
New Horizon Health
Burning Rock
Berry Oncology
Shanghai Kunyuan Biotechnology
Oncognostic
Epigenomics
Abbott
Qiagen
iStat Biomedical
Segment by Type
Colorectal Cancer
Liver Cancer
Lung Cancer
Other
Segment by Application
Hospital
Medical Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cancer Early Detection and Screening report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Early Detection and Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Colorectal Cancer
1.2.3 Liver Cancer
1.2.4 Lung Cancer
1.2.5 Other
1.3 Market by Application
1.3.1 Global Cancer Early Detection and Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Medical Center
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Early Detection and Screening Market Perspective (2018-2029)
2.2 Cancer Early Detection and Screening Growth Trends by Region
2.2.1 Global Cancer Early Detection and Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cancer Early Detection and Screening Historic Market Size by Region (2018-2023)
2.2.3 Cancer Early Detection and Screening Forecasted Market Size by Region (2024-2029)
2.3 Cancer Early Detection and Screening Market Dynamics
2.3.1 Cancer Early Detection and Screening Industry Trends
2.3.2 Cancer Early Detection and Screening Market Drivers
2.3.3 Cancer Early Detection and Screening Market Challenges
2.3.4 Cancer Early Detection and Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Early Detection and Screening Players by Revenue
3.1.1 Global Top Cancer Early Detection and Screening Players by Revenue (2018-2023)
3.1.2 Global Cancer Early Detection and Screening Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Early Detection and Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Early Detection and Screening Revenue
3.4 Global Cancer Early Detection and Screening Market Concentration Ratio
3.4.1 Global Cancer Early Detection and Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Early Detection and Screening Revenue in 2022
3.5 Cancer Early Detection and Screening Key Players Head office and Area Served
3.6 Key Players Cancer Early Detection and Screening Product Solution and Service
3.7 Date of Enter into Cancer Early Detection and Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Early Detection and Screening Breakdown Data by Type
4.1 Global Cancer Early Detection and Screening Historic Market Size by Type (2018-2023)
4.2 Global Cancer Early Detection and Screening Forecasted Market Size by Type (2024-2029)
5 Cancer Early Detection and Screening Breakdown Data by Application
5.1 Global Cancer Early Detection and Screening Historic Market Size by Application (2018-2023)
5.2 Global Cancer Early Detection and Screening Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cancer Early Detection and Screening Market Size (2018-2029)
6.2 North America Cancer Early Detection and Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cancer Early Detection and Screening Market Size by Country (2018-2023)
6.4 North America Cancer Early Detection and Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Early Detection and Screening Market Size (2018-2029)
7.2 Europe Cancer Early Detection and Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cancer Early Detection and Screening Market Size by Country (2018-2023)
7.4 Europe Cancer Early Detection and Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Early Detection and Screening Market Size (2018-2029)
8.2 Asia-Pacific Cancer Early Detection and Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cancer Early Detection and Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Cancer Early Detection and Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Early Detection and Screening Market Size (2018-2029)
9.2 Latin America Cancer Early Detection and Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cancer Early Detection and Screening Market Size by Country (2018-2023)
9.4 Latin America Cancer Early Detection and Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Early Detection and Screening Market Size (2018-2029)
10.2 Middle East & Africa Cancer Early Detection and Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cancer Early Detection and Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Cancer Early Detection and Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Exact Sciences
11.1.1 Exact Sciences Company Detail
11.1.2 Exact Sciences Business Overview
11.1.3 Exact Sciences Cancer Early Detection and Screening Introduction
11.1.4 Exact Sciences Revenue in Cancer Early Detection and Screening Business (2018-2023)
11.1.5 Exact Sciences Recent Development
11.2 Grail
11.2.1 Grail Company Detail
11.2.2 Grail Business Overview
11.2.3 Grail Cancer Early Detection and Screening Introduction
11.2.4 Grail Revenue in Cancer Early Detection and Screening Business (2018-2023)
11.2.5 Grail Recent Development
11.3 Genetron Health
11.3.1 Genetron Health Company Detail
11.3.2 Genetron Health Business Overview
11.3.3 Genetron Health Cancer Early Detection and Screening Introduction
11.3.4 Genetron Health Revenue in Cancer Early Detection and Screening Business (2018-2023)
11.3.5 Genetron Health Recent Development
11.4 New Horizon Health
11.4.1 New Horizon Health Company Detail
11.4.2 New Horizon Health Business Overview
11.4.3 New Horizon Health Cancer Early Detection and Screening Introduction
11.4.4 New Horizon Health Revenue in Cancer Early Detection and Screening Business (2018-2023)
11.4.5 New Horizon Health Recent Development
11.5 Burning Rock
11.5.1 Burning Rock Company Detail
11.5.2 Burning Rock Business Overview
11.5.3 Burning Rock Cancer Early Detection and Screening Introduction
11.5.4 Burning Rock Revenue in Cancer Early Detection and Screening Business (2018-2023)
11.5.5 Burning Rock Recent Development
11.6 Berry Oncology
11.6.1 Berry Oncology Company Detail
11.6.2 Berry Oncology Business Overview
11.6.3 Berry Oncology Cancer Early Detection and Screening Introduction
11.6.4 Berry Oncology Revenue in Cancer Early Detection and Screening Business (2018-2023)
11.6.5 Berry Oncology Recent Development
11.7 Shanghai Kunyuan Biotechnology
11.7.1 Shanghai Kunyuan Biotechnology Company Detail
11.7.2 Shanghai Kunyuan Biotechnology Business Overview
11.7.3 Shanghai Kunyuan Biotechnology Cancer Early Detection and Screening Introduction
11.7.4 Shanghai Kunyuan Biotechnology Revenue in Cancer Early Detection and Screening Business (2018-2023)
11.7.5 Shanghai Kunyuan Biotechnology Recent Development
11.8 Oncognostic
11.8.1 Oncognostic Company Detail
11.8.2 Oncognostic Business Overview
11.8.3 Oncognostic Cancer Early Detection and Screening Introduction
11.8.4 Oncognostic Revenue in Cancer Early Detection and Screening Business (2018-2023)
11.8.5 Oncognostic Recent Development
11.9 Epigenomics
11.9.1 Epigenomics Company Detail
11.9.2 Epigenomics Business Overview
11.9.3 Epigenomics Cancer Early Detection and Screening Introduction
11.9.4 Epigenomics Revenue in Cancer Early Detection and Screening Business (2018-2023)
11.9.5 Epigenomics Recent Development
11.10 Abbott
11.10.1 Abbott Company Detail
11.10.2 Abbott Business Overview
11.10.3 Abbott Cancer Early Detection and Screening Introduction
11.10.4 Abbott Revenue in Cancer Early Detection and Screening Business (2018-2023)
11.10.5 Abbott Recent Development
11.11 Qiagen
11.11.1 Qiagen Company Detail
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Cancer Early Detection and Screening Introduction
11.11.4 Qiagen Revenue in Cancer Early Detection and Screening Business (2018-2023)
11.11.5 Qiagen Recent Development
11.12 iStat Biomedical
11.12.1 iStat Biomedical Company Detail
11.12.2 iStat Biomedical Business Overview
11.12.3 iStat Biomedical Cancer Early Detection and Screening Introduction
11.12.4 iStat Biomedical Revenue in Cancer Early Detection and Screening Business (2018-2023)
11.12.5 iStat Biomedical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
